DME

Latest News

While diabetic retinopathy is not one of the leading causes of blindness and vision impairment globally, the widespread prevalence of diabetes warrants the need for resources.
AOA 2025: What role do optometrists play in the diabetic pandemic?

July 2nd 2025

Nicholas R. Green, OD, FAAO, gave a presentation on the management and treatment of diabetes and its ocular effects at the American Optometric Association’s Optometry’s Meeting 2025 in Minneapolis, Minnesota.

White pills in measuring cup Image credit: AdobeStock/nucia
HIV drug lamivudine holds potential for patients with DME, researchers find

June 11th 2025

Empty doctor's office. Image credit: AdobeStock/xixinxing
Innovent Biologics completes first patient dosing in its phase 2 clinical trial assessing efdamrofusp alfa in patients with DME

May 7th 2025

FDA issues CRL for extended dosing regiment for Eylea HD for wet AMD, DME, and DR - Image credit: Adobe Stock / ©Michele Ursi
Regeneron announces FDA issues CRL for aflibercept 8 mg (Eylea HD) sBLA

April 21st 2025

Older man administering eye drops Image credit: AdobeStock/StockImageFactory
Oculis completes enrollment in phase 3 DIAMOND trials for DME eye drop candidate

April 14th 2025

Video Interviews
Latest CME Events & Activities

Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data

View More

Practical Approaches to Modern Dry Eye Treatment and Management

June 25, 2025

Register Now!

Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy

View More

Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)

View More

Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)

View More

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)

View More

Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)

View More

Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)

View More

Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)

View More

Retina Specialists: Join us in Long Beach

July 31, 2025 - August 2, 2025

Register Now!

SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application

View More

3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between

September 6, 2025

Register Now!

Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D

View More

EyeCon 2025

September 26-27, 2025

Register Now!

Optometrists: Earn COPE CE Credits in Portland or Virtually

October 16-17, 2025

Register Now!

Join us at The Ophthalmology Meeting in Orlando this October

October 18, 2025

Register Now!

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)

View More

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)

View More

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

Expert Perspectives on Technological Advances in Cataract Surgery

View More

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

View More

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

View More

(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

View More

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

View More

(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention

View More

(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

View More

(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

View More

(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

View More

(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

View More

More News

© 2025 MJH Life Sciences

All rights reserved.